Adverse Drug Reaction Reports in an Antiretroviral Treatment Centre in Jos, North Central Nigeria
L. O. Ogwuche, V. B. Ojeh, I. A. London, N. Naima, C. Dady, A. I. Finangwai, I. O. Abah, K. D. Falang, P. Agaba, O. A. Agbaji
Journal of Pharmaceutical Research International · pp. 714–721 · Published 30 Jan 2014
10.9734/BJPR/2014/6520Abstract
Background: Reports of adverse drug reactions (ADR) in the era of increasing uptake of antiretroviral drugs particularly in Sub Saharan Africa and especially in Nigeria have been on the rise. Aim: We set out to collate and characterize the pattern of adverse drug reactions in patients on antiretroviral drugs in our treatment centre. Study Design: Retrospective Cross sectional study Place and Duration of Study: The study was carried out at the APIN Centre, Jos University Teaching Hospital, Plateau State, North Central Nigeria from July 2010 to December 2012. Methodology: We reviewed the case files and data base entries of 215 patients attending our treatment centre. These are patients who had reported cases of adverse drug reactions. We took note of demographic profiles of the patients, the medical history as well as the different types of antiretroviral drugs the patients were taking. The types of adverse drug reactions and offending drugs were noted and categorized using descriptive statistics. Results: Out of 215 case files and databases of patients in which there were reports of adverse drug reactions, 80 (37.2%) were male and 135 (62.8%) were female. Almost thirty two percent (31.6%) of the patients were on Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP), 14.9%on Zidovudine/Lamivudine/Tenofovir/Lopinavir/ritonavir (AZT/3TC/TDF/LPV/r), 13.5% on Stavudine/Lamivudine/Nevirapine (D4T/3TC/NVP). Anemia was the most common ADR representing 23.4% of all ADRs and 29.3% of all ADRs were associated with Zidovudine. Conclusion: Our study shows that in antiretroviral treatment centre such as our own, healthcare providers/practitioners should take particular note of troubling adverse drug reactions such as anaemia. Healthcare providers/practitioners should particularly have in place alternative treatment regimens as these adverse drug reactions may be potential cause of medication non adherence which in the long run lead to treatment failure.
Cited by 1
Yohanna Kambai Avong, Bolajoko Jatau, Ritmwa Gurumnaan · PLOS ONE · 2018
Related research
- Comprehensive Roles of TP53 in Cell Signaling, Apoptosis and Carcinogenesis – A Review — shares topic coverage
- Postoperative Use of Cyclosporine, Prednisolone or a Cyclosporine/Prednisolone Combination to Treat Inflammation of the Conjunctiva Following Trabeculectomy in Rabbits — shares topic coverage
- Effectiveness of Neurofeedback and Drug Therapy on ADHD Children and Its Impact on Happiness of Their Mothers — shares topic coverage
- A Systematic Literature Review of Current Therapeutic Approaches for COVID-19 Patients — shares topic coverage
- Role of Pharmacist in Addressing the Adverse Drug Reactions and Improving the Knowledge of Patients Regarding Their Drug Therapy at Government Civil Hospital Khairpur, Sindh, Pakistan — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.